Infections caused by multidrug-resistant Pseudomonas aeruginosa are considered a major public health problem. Antibiotic options are scarce but new drugs are emerging and more maybe available in the near future. We will discuss this important topic with experts in the field.
This episode of Editors in Conversation is brought to you by the Antimicrobial Agents and Chemotherapy Journal and hosted by AAC Editor in Chief, Cesar Arias. AAC is available at asm.org/aac.
Follow Cesar on twitter at / superbugdoc for AAC updates.
Subscribe to the podcast at asm.org/eic
👍 Subscribe to ASM's KZitem channel at goo.gl/mOVHlK
✅ Become a member today at asm.org/Membership
🔬 Learn more about the American Society for Microbiology at www.asm.org
📱 Join us on social:
Facebook: / asmfan
Twitter: / asmicrobiology
Instagram: / asmicrobiology
Негізгі бет Ғылым және технология Treatment of Resistant Pseudomonas Aeruginosa Infections
Пікірлер: 22